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Abstract 
Post-stroke dysphagia (a difficulty in swallowing after a stroke) is a common and 
expensive complication of acute stroke and is associated with increased mortality, 
morbidity and institutionalisation due in part to aspiration, pneumonia and 
malnutrition. Although most patients recover swallowing spontaneously, a significant 
minority still have dysphagia at 6 months. Although multiple advances have been 
made in the hyper acute treatment of stroke and secondary prevention, the 
management of dysphagia post-stroke remains a neglected area of research, and its 
optimal management, including diagnosis, investigation and treatment, have still to 
be defined. 
 
 
Background 
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Stroke is recognised as a leading cause of death and disability worldwide and is 
associated with multiple medical complications leading to prolonged hospital 
admissions and significant health care costs.(1) Post-stroke dysphagia (PSD), defined 
here as difficulty in swallowing after a stroke, is a common complication affecting 
many patients in the first few hours and days after ictus. PSD is associated with 
increased mortality and morbidity due in part to aspiration, pneumonia and 
malnutrition. Although many stroke patients recover swallowing spontaneously, 11-
50% still have dysphagia at 6 months.(2, 3) Persistent dysphagia independently 
predicts poor outcome and institutionalisation.(4) Dysphagia leading to aspiration of 
ingested foods, liquids or oral secretions, is thought to be the primary risk factor for 
pneumonia after stroke.(5) Dysphagic patients are three times, and those with 
confirmed aspiration eleven times, more likely to develop pneumonia.(1, 6) A recent 
large retrospective US study of stroke patients quantified the individual cost of 
pneumonia and associated mortality as $21,338. The relative risk of hospital death in 
stroke patients with pneumonia is 5.7 (95% CI, 5.4-6.0).(5) 
 
Although multiple advances have been made in the hyper acute treatment of stroke 
(e.g. with thrombolysis, mechanical thrombectomy, and hemicraniectomy), and 
secondary prevention (antithrombotics, blood pressure lowering, lipid lowering), the 
management of PSD remains a neglected area of research. As such, the optimal 
management of PSD, including diagnosis, investigation and treatment, remains to be 
defined. 
Epidemiology of PSD 
Globally, fifteen million people suffer a stroke annually *Atlas 7 and up to 65% have 
swallowing problems of whom half will be symptomatic.(7) Some early studies 
included people with diagnosed dysphagia who were referred for further assessment 
and this increased artificially the rate of aspiration.(8, 9) The true prevalence of 
dysphagia can only be established by studying an unselected stroke population (3, 10) 
and there have been no such recent studies. 
 
In acute stroke the prevalence of dysphagia has been reported as between 28 and 
65%,(3, 10-12) a variation that reflects differences in the assessment of dysphagia, 
setting, and timing of the test used. Dysphagia improves significantly during the early 
days and after two weeks 90% of patients swallow safely.(3, 7) although a small 
proportion will have problems for longer.(2) Further, some patients who appear to 
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have a safe swallow at three months are found to have difficulties again at six.(3, 10) 
In general, if the swallow does not show any signs of recovery in the first ten days 
after stroke, the return of a safe swallow may take up two or three months to show 
signs of recovery.(13) 
 
In hyperacute stroke studies, swallowing has been assessed using a water swallow 
test, a screening test rather than full assessment.(14) Many subsequent swallow 
screens have been based on this with or without a scoring mechanism.(15-18) Some 
tests require specialist training or are copyrighted (e.g. TOR-BSST).(15) Assessment 
later after the stroke is more comprehensive but will detect fewer cases as swallowing 
improves recovers.(10, 19) It is difficult to estimate how many patients simply have 
difficulty swallowing and how many are also aspirating as few studies have performed 
routine videofluoroscopy (VFS) in the first few days. 
 
It is important to decide which aspect of swallowing, for example, clinical dysphagia or 
radiological aspiration, is the focus of study. This will determine the type of 
assessment required and the relevance to clinical practice. For example, it remains 
unclear whether a finding of asymptomatic aspiration on fibreoptic endoscopic 
evaluation of swallowing (FEES) is relevant or whether a minor tongue movement 
abnormality on clinical examination is important if it does not cause symptoms. 
 
Mechanisms of post-stroke dysphagia  
PSD is thought to be due to damage to the cortex and subcortical structures. Cortical 
re-organisation then leads to swallowing recovery. Studies using transcranial 
magnetic stimulation (TMS) have shown that pharyngeal musculature is represented 
bilaterally, but asymmetrically, in the cerebral cortex of healthy volunteers.(20) A 
stroke lesion affecting the ‘dominant swallowing hemisphere’ may therefore be 
responsible for dysphagia following unilateral hemispheric stroke.  
 
TMS studies in patients with hemispheric strokes showed that patients with dysphagia 
have smaller pharyngeal responses from the unaffected hemisphere as compared to 
non-dysphagic patients. This suggests that in dysphagic patients the non-dominant 
unaffected hemisphere may not be able to maintain swallowing.(21) In an attempt to 
understand the mechanism for recovery of swallowing after stroke, swallowing was 
studied by VFS and TMS in 28 hemispheric stroke patients at baseline (71% 
dysphagic), at 1 month (46% dysphagic) and at 3 months (41% dysphagic) to 
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examine pharyngeal cortical representation at each time point. Subjects who were 
non-dysphagic at baseline after hemispheric stroke had greater pharyngeal cortical 
representation in the contralesional hemisphere as compared to dysphagic subjects. 
TMS follow-up data at one and three months indicated that subjects who recovered 
swallowing function had significantly greater pharyngeal representation in the 
unaffected hemisphere as compared to baseline when dysphagic. These findings 
suggest that re-organisation in the contralesional hemisphere is key in swallowing 
recovery.(22) This is illustrated in Figure 1: the subject had a left hemispheric stroke 
and the shaded areas correspond to the cortical areas representing the pharyngeal 
muscles with TMS; the subject recovered swallowing function at one month in parallel 
with expansion of pharyngeal cortical representation in the unaffected right 
hemisphere.  
 
A recent functional magnetic resonance imaging study comparing cortical activations 
during swallowing between dysphagic hemispheric stroke patients and healthy 
subjects confirmed compensatory recruitment and activation of regions of the cerebral 
cortex in the intact hemisphere, supporting the theory that changes in the unaffected 
hemisphere are crucial in swallowing recovery.(23) Similarly, a 
magnetoencephalography (MEG) study imaged swallowing activations in subacute 
stroke patients with and without dysphagia and compared findings with healthy 
controls.(24) Increased pharyngeal motor representation in the contralesional 
hemisphere in hemispheric stroke patients without dysphagia was reported, consistent 
with findings by others. By contrast, in the dysphagic stroke patients there was 
almost absent cortical activation in the unaffected hemisphere during swallowing. 
 
Neuroplasticity could play a significant role in the recovery of swallowing function. 
Neuroplasticity is an experience-driven process, which leads to long-term 
morphological or functional changes in the central nervous system and can result in 
behavioural changes.(25) Environmental changes, conditioning stimuli and brain 
lesions can evoke such plastic changes. Brain injury, such as hemispheric stroke 
affecting the pharyngeal motor cortex, is an example of this with plastic changes in 
the unaffected hemisphere occurring during recovery of swallowing function.(26) 
Traditionally, it has been believed that plastic changes occur at a synaptic level, when 
neurons fire together with co-existing activation of pre- and post- synaptic 
membranes leading to strengthening of the synapse. 
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Complications of PSD 
Complications of dysphagia include the consequences of aspiration: pneumonia, 
recurrent cough and choking, and those of modifications to dietary and fluid intake: 
compromised nutrition and hydration, reduced quality of life and social isolation.  
 
Pneumonia is a frequent complication of stroke, occurring in around 10% of 
hospitalised patients.(27) In those at greatest risk because of advanced age, severe 
stroke and PSD, the incidence of pneumonia may be as high as 40%.(28) Confirmed 
aspiration is strongly associated with pneumonia (relative risk 11.56; 95% CI 3.36 to 
39.77).(7) Current thinking recognises the potential interplay between poor oral 
health, aspiration and immune suppression in determining susceptibility to 
pneumonia.(29) Pneumonia most often presents in the first week after a stroke, 
probably because of the high prevalence of dysphagia and the extent of immune 
suppression during the acute phase. Nevertheless, the diagnosis of pneumonia 
complicating stroke remains challenging as its presentation may be non-specific and 
investigations such as chest radiography and microbiological specimens are of limited 
value.(30) This has significant implications for clinical care and research that 
considers pneumonia as a trial endpoint and recent consensus diagnostic criteria have 
been proposed to address this.(31) 
 
Patients developing pneumonia are more likely to die or survive dependent on 
others,(27, 32, 33) and have a longer stay in hospital. As compared to alternative 
settings, care on a stroke unit compared to alternative settings reduces the frequency 
of pneumonia (odds ratio 0.60; 95% CI 0.42 to 0.87).(34) Little is known about the 
impact of particular care processes such as positioning, early swallow screening and 
oral care practices. The time trend in pneumonia prevalence in stroke units is unclear, 
for example, one registry study suggested no significant change in pneumonia 
prevalence between 1998 and 2007.(35) Pneumonia remains an important and 
modifiable complication of stroke, and strategies to prevent it such as reducing 
aspiration could significantly improve outcomes. 
  
Compromised nutrition, hydration and poor quality of life caused by PSD have 
attracted less clinical and research attention than pneumonia. In a systematic review 
from 2009 the chance of malnutrition increased in patients with dysphagia particularly 
in the post-acute phase.(36) The conclusions were limited by widely varying 
definitions and prevalence of both dysphagia and malnutrition. The validity and utility 
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of the available methods for assessing nutritional status in patients with stroke such 
as the Demiquet Index, anthropometry, and those for hydration status, are unclear 
and need further evaluation. Dysphagia related quality of life tools such as SWAL-
QUAL and SWAL-CARE are available (37) but these were not derived in patients with 
stroke and require evaluation in this setting. 
Diagnosis: clinical and instrumental 
Dysphagia can be diagnosed by clinical bedside assessment (CBA), or instrumentally 
by VFS, or by FEES. CBA consists of a detailed oral examination and an assessment 
with food and liquid to ascertain oral and pharyngeal competency. Several 
methodological variations have been reported.(38) CBA predicts pharyngeal 
dysphagia poorly and has been criticised for its inaccuracy in identifying 
aspiration,(39, 40) missing up to 40% of people who aspirate.(39) 
 
VFS is an instrumental assessment of swallowing and involves swallowing a 
radiological contrast agent such as barium. It is expensive as it needs a radiology 
suite and often a number of different staff. Many patients are too ill to travel to 
radiology and sit up for long enough to be assessed. It involves radiation exposure 
(although this is of less relevance to stroke patients) and is not readily repeatable. 
Hence, it is impractical to perform VFS in every case. 
 
In FEES a laryngoscope is passed trans-nasally to the hypo-pharynx to view the 
larynx and pharynx. Food and drinks are dyed to aid visualisation of the bolus. FEES 
allows an assessment of the anatomy, secretions and of food and drink management. 
Information is obtained on the ability to protect the airway, timing of the bolus 
through the hypopharynx and ability to clear the bolus during the swallow. It also 
allows the clinician to see pooling and residue in the hypo pharynx and detect 
aspiration.(41, 42) The equipment is portable, sitting is not essential, and the 
procedure can be performed at the bedside. It is a repeatable, and safe allowing more 
swallows to be tested. Patients can be assessed while eating a full meal rather than 
with the limited number of spoonful’s of contrast given during VFS. However, FEES is 
not routinely available in many hospitals worldwide which, like VFS, limits the number 
of centres which could participate in research using it as an assessment.  
 
VFS and FEES are considered interchangeable in clinical practice, especially when 
examining aspiration or penetration,(42-47) and they are the only two assessments 
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that can diagnose aspiration reliably.(48) VFS has been considered the gold standard 
for the diagnosis of dysphagia, but FEES is increasingly seen as a cost-effective, 
portable, and reliable alternative.(48) Validation of FEES against VFS showed high 
sensitivity and specificity.(42, 49, 50) In one study FEES was shown to detect 
aspiration more reliably than VFS.(47) Other assessments, such as cervical 
auscultation or pulse oximetry are other potential approaches. 
  
In conclusion, instrumental assessment is considered the gold standard in the 
diagnosis of dysphagia, but requires specialist staff and equipment and therefore 
cannot readily be conducted within a few hours of stroke onset, as would be needed in 
a study of early intervention. CBA is the only option in this situation but is not as 
reliable.  
Dysphagia management 
The primary aim of dysphagia management has been to reduce aspiration and to 
manage swallowing difficulties rather than rehabilitate the swallow. This is partly due 
to the heterogeneity of swallowing difficulties and developing knowledge of the normal 
and disordered swallow. Management includes modifying food and fluid, altering 
posture and changing swallowing strategies with some rehabilitative techniques. 
These may be used independently but are mostly used together. Management 
depends on whether the focus is on risk of aspiration or level of swallow breakdown 
and can be individualised. 
 
Compensatory techniques support management of food and drink within a person’s 
current situation and reduce aspiration risk. They are short-term adjustments and 
may not improve the physiology of the swallow or promote neural network swallow 
recovery. Postural techniques (e.g. chin tuck) redirect the bolus and change 
pharyngeal dimensions. Compensatory swallow techniques such as the effortful 
swallow aim to increase the efficacy and safety of swallowing. There is some evidence 
of a reduction in aspiration with these techniques.(51, 52) 
 
Thickening liquids slows the bolus and increases bolus cohesion leading to a reduction 
in penetration and aspiration.(53) The quality and extent of modification of food and 
fluids is inconsistent and subjective as thickness of fluids depends on the base fluid, 
temperature, the individual making the drink, and the type of thickener, resulting in 
variability within and between patients.(54) 
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Rehabilitation techniques such as oral and lingual exercises tend to focus on strength 
and endurance.(55) They result in an increase in isometric pressure, but are aimed at 
specific parts of the swallow so it is not clear how they generalise to the dynamic 
swallow. Other approaches report a more explicit focus on motor learning principles 
and the functional swallowing process. One of these with some evidence of 
effectiveness is the McNeill Dysphagia Therapy programme.(56) More recently neuro-
stimulation techniques for rehabilitation have been employed, such as TMS, 
pharyngeal electrical stimulation (PES) and neuromuscular electrical stimulation; 
there is some evidence that these may reduce aspiration, pharyngeal residue, length 
of stay in hospital, and improved swallowing performance.(57) Recent reviews of 
dysphagia management report limited consistency of evidence for interventions, but 
with some evidence of effectiveness for behavioural interventions and PES on aspects 
of swallow and functional outcomes.(52, 58) 
  
Although there is little evidence for postural and compensatory techniques, these are 
widely but variably used leading to difficulties in establishing what ‘usual care’ is in a 
research context. This could be addressed by cluster rather than patient level 
randomisation. Issues around subjectivity of fluid modification can be addressed by 
using pre-thickened bolus which has been shown to be more consistent.(55) 
 
Medical treatment of dysphagia 
There is no established medical treatment for PSD, although multiple studies have 
investigated a variety of interventions, including therapist-delivered, behavioural, 
acupuncture, electrical or magnetic stimulation, and drugs. Completed randomised 
controlled trials are summarised in a Cochrane Collaboration review (58) that is 
currently being updated.(59) Table 1 summarises the main effects of a variety of 
treatments used in these trials on a number of different outcomes. Overall, there were 
few studies when considered by type of treatment, most were single-centre, and all 
were small. Interpretation of them is further confounded as many involved mixed 
populations of patients with different types of dysphagia, not just PSD, and many 
trials recruited patients over a wide time range after stroke. Overall, the quality of 
most trials judged using Cochrane Collaboration criteria was low to moderate although 
a few were high quality. The existing evidence demonstrates the necessity for large 
high quality dysphagia-treatment trials. 
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Prevention of post-stroke pneumonia 
Post-stroke pneumonia is due to a combination of dysphagia, aspiration,(7) and 
stroke-induced immunosuppression.(60) Prevention of pneumonia therefore includes 
early identification of dysphagia, interventions to reduce the volume and frequency of 
aspiration and the pathogenicity of the aspirate, enhancement of laryngeal sensation 
and protective mechanisms such as cough, and promotion of cortical plasticity to 
enhance recovery of the swallow.  
 
Stroke unit care is associated with significant reductions in the incidence of 
pneumonia.(34) This is likely to be due to timely screening for dysphagia, modification 
of the consistency of diet and fluids and/or provision of enteral feeding(61, 62) and 
early mobilisation.(63, 64) Pharmacologic approaches could further decrease the risk 
of pneumonia. Selective oral decontamination lowers oropharyngeal colonisation with 
pathogenic Gram negative bacteria, and was associated with a significant reduction in 
pneumonia in a study of 203 patients with acute stroke.(65) Prevention of vomiting 
and regurgitation is another promising approach, as stroke does not only cause 
dysphagia, but is also associated with lower oesophageal sphincter dysfunction, 
gastro-paresis, increased gastric residual volume and gastro-oesophageal reflux.(66) 
A recent randomized controlled study of the antiemetic agent metoclopramide in 60 
patients with acute stroke fed via nasogastric tubes showed a 69% reduction in 
pneumonia with regular treatment.(67) 
 
Pneumonia after stroke could potentially be prevented by the use of prophylactic 
antibiotics. A Cochrane review of five studies including 506 patients demonstrated 
that prophylactic antibiotics significantly reduced post-stroke infection but had no 
effect on mortality.(68) Most of the included trials used broad-spectrum antibiotics, 
started within 24 hours of stroke onset and continued for 3-5 days.(69, 70) While 
antibiotic prophylaxis prevented infections overall, there was no reduction in 
pneumonia. A recently published large randomised trial of prophylactic ceftriaxone in 
2250 unselected patients with acute stroke confirmed these findings with an overall 
reduction in infections, but no effect on pneumonia.(71) The results of a further large 
study of antibiotic prophylaxis (Stroke-Inf) are likely to be available by the end of 
2015 (http://www.isrctn.com/ISRCTN37118456). 
 
Cough is a well- known side effect of angiotensin converting enzyme inhibitors 
(ACEIs) and could potentially reduce pneumonia, but this has only been tested in 
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patients with chronic stroke.(72) Cilostazol, an antiplatelet agent with vasodilator 
effects has also been shown to reduce pneumonia in the chronic phase of stroke; the 
mechanism for this is unknown, but might involve bradykinin and substance P, as for 
ACEIs.(73) Excessive tracheobronchial sections (bronchorrhoea) have been described 
in posterior circulation strokes, and anticholinergic agents could reduce secretions and 
pneumonia in this group.(74) 
 
Pneumonia is an early complication of stroke, and usually associated with aspiration 
soon after the acute event.(75) The risk of aspiration declines within the first two 
weeks after stroke.(76) Therefore, prevention should be started early and continue 
over the first two weeks, the period when patients are most at risk of aspiration and 
pneumonia. As there is no agreed definition of post-stroke pneumonia,(31) 
comparison of the effectiveness of interventions aimed at prevention of pneumonia is 
difficult. Future studies should use agreed definitions.(30) 
 
Oral Care  
Poor oral care and dental hygiene increase risk of pneumonia, cause discomfort and 
reduce quality of life after stroke. There are guidelines for best practice.(77) The 
majority of data, on which the recommendations are based, are from ventilated 
patients on intensive care units.(78, 79) Nursing home residents, people with 
dementia or with learning difficulties are high risk groups for poor mouth care. Poor 
dental hygiene is recognised as being associated with vascular disease and is more 
common in older people. It is likely that poor oral care is a cause for pneumonia in 
this group, particularly if there is also dysphagia and in individuals who are enterally 
fed (Beavan, Meagher & Robertson, unpublished). 
 
Patients with neurodisability have difficulty undertaking their own oral and dental care 
due to physical, perceptual and cognitive difficulties and therefore rely on help. They 
may be reluctant to ask for help, as oral care is not seen as a priority.(80) Lack of 
help is associated with poor oral and dental care. 
 
The best way to deliver oral care is uncertain and practice varies widely.*87 Nurses 
worry about causing aspiration and therefore, although recommended, few use 
toothbrushes or toothpaste. Electric and suction toothbrushes are a potential option, 
but they are expensive and it is uncertain if they are of benefit after acute stroke.(81) 
The flora of the oral cavity is altered by the stroke itself,(65) by concurrent use of 
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antibiotics, the development of candida infections and by the build-up of 
oropharyngeal residues and dental plaque. The solutions used for oral care vary 
between units. The best agent to use in stroke patients is unclear but using some 
form of diluted chlorhexidine as part of an oral care regime, as in intensive care, may 
be beneficial.(78) The effectiveness and risks of pineapple juice (which contains 
sugar), artificial saliva and glycerine sticks are unclear. Glycerine sticks are 
discouraged as they may dry the mouth. The production and consistency of saliva 
may change post stroke and drying of the oral cavity may be affected by poor oral 
closure and positioning.  
Patient and carer perspectives 
When admitted to hospital following an acute stroke, patients and their relatives are 
often unaware that stroke can cause swallowing problems. They are frequently 
surprised, and distressed, when a ‘nil by mouth’ order is placed until the swallow has 
been checked although this practice is evidence-based and supported by stroke 
guidelines.(82) This surprise is perhaps understandable as dysphagia is not a 
symptom a lay person would associate with stroke and does not feature in the act 
FAST campaign, even though dribbling saliva is common. 
 
A swallow screen should be performed as early as possible in the person's 
assessment. If the swallow is considered unsafe, and the person is put ‘nil by mouth’, 
the patients’ and carers’ distress are frequently exacerbated. Further problems can 
ensue if no one who can do a more detailed assessment is available to say whether 
the patient must remain nil by mouth, or if they could manage a modified diet or 
fluids safely. Even a modified diet may cause further distress as it can be aspirated, 
causing coughing, or if the patient is unable to swallow it, collect in a cheek causing 
"pouching".(83) Attention to oral care is particularly important in these patients for 
safety and because retained food debris can cause halitosis, causing further indignity 
and carer distress. 
 
All staff working with stroke patients should have the knowledge and skills appropriate 
to their role in the pathway *91 including those for the detection and management of 
dysphagia and its complications. Inter-professional competences have been developed 
to inform the training and organisation of teams in all aspects of dysphagia.(84) 
Implementation has the potential to reduce waiting times for swallowing assessments, 
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improve patient’s safety at mealtimes, and optimising dysphagia management, 
improving both patients and carers experience.  
 
Training of carers in addition to training of staff is recommended because difficulties 
with swallowing may arise not only in hospital bat also after discharge, and those in 
close contact with the patient have the unique opportunity to notice the signs: 
delayed cough after seemingly drinking competently. Patients are frequently 
distressed by the constant stream of saliva. Even if they are able to eat, Patients may 
not eat in the presence of others because of failing to meeting other people's 
expectations of well-mannered behaviour. This not only affects the patient but also 
their carers and friends.(85) Swallowing problems may persist long-term, and low 
mood and clinical depression may result.(86) 
 
Trial design considerations 
The design and results of completed trials help when designing future studies. Key 
trial designs cover both generic and dysphagia-specific factors (table 2). Trials must 
be designed to minimise the potential for bias and therefore use true randomisation 
that conceals allocation from the investigator, and outcomes must be assessed 
blinded to treatment. Some potential treatments for dysphagia may allow a double-
blind design by using matching placebo for drug therapy or sham intervention for 
device studies.(87) Where possible, trials should allow masking of the treating 
healthcare professional as well as the patient. However, large trials may need to have 
no placebo or sham if they are to replicate real-world use of the intervention. Either 
way, trials involving acupuncture, physical stimulation or behavioural therapies will 
need a treating speech and language therapist or other professional and therefore will 
inherently have to be open label, albeit with blinded outcome assessment. 
 
Dysphagia-specific trial design considerations cover the type of intervention and 
outcomes. The primary outcome will depend on whether the trial is assessing 
primarily mechanisms (phase II) or efficacy (phase III or IV). Mechanistic studies 
need to focus on tolerability of the intervention and whether prognostic measures of 
aspiration (with assessment using FEES or VFS (88)) and dysphagia (using a clinical 
scale such as the DSRS (57)) are reduced. In contrast, phase III trials will need to 
assess real world outcomes that may be dysphagia related (such as pneumonia or 
need for PEG feeding) or functional (such as the modified Rankin Score). Once the 
primary outcome is decided, an optimal method of analysis should be used to 
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minimise sample size for a given power (with power typically set at 0.90); efficient 
statistical analyses can reduce sample size in stroke trials by 20-30%.(89) 
 
A number of trials or observational studies are ongoing, as summarised in (90) and 
table 3, the latter focussing on ongoing studies. 
 
Summary 
The optimal diagnosis and treatment of PSD remains unclear and reported trials do 
not define optimal management. Ongoing studies may identify new strategies 
although their number is few. Nevertheless, their results, whether positive, neutral or 
negative, will help identify strategies that need testing or rejecting; if any trial is 
positive then a further one will probably be needed to validate the findings. 
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Figure 1. Expansion of pharyngeal motor cortex on unlesioned hemisphere during 
swallowing recovery after stroke. Magnetic resonance image with co-registered 
topographic data from transcranial magnetic stimulation at baseline, one month, and 
three months after enrolment.(22) 
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